| ACE2 | Angiotensin Converting Enzyme 2 |
| Ala | Alanine |
| AMBER | Assisted model building with energy refinement |
| ANG II | Angiotensin II |
| AR1 | Androgen receptor 1 |
| ARBs | Angiotensin II receptor blockers |
| Arg | Arginine |
| AT1(2) | ANG II receptors type 1 (2) |
| Azil | Azilsartan |
| Bis | Bisartan |
| BPT | Biphenyl tetrazole |
| Cande | Candesartan |
| 3CLpro | 3C-like protease |
| COVID-19 | Coronavirus diseases |
| CRS | Charge-relay system |
| DIZE | Deminazene aceturate |
| DNA | Deoxyribonucleic acid |
| Epro | Eprosartan |
| EXP3174 | Losartan carboxylic acid |
| His | Histidine |
| ID | Identifier |
| Ile | Isoleucine |
| Irbe | Irbesartan |
| Leu | Leucine |
| Lo | Losartan |
| Lys | Lysine |
| MD | Molecular dynamics |
| mRNA | Messenger ribonucleic acid |
| NEP | Neprilysin |
| Olme | Olmesartan |
| PDB | Protein Data Bank |
| Phe | Phenylalanine |
| Pro | Proline |
| RAS | Renin–angiotensin system |
| RM1 | Recife model 1 |
| RMSD | Root-mean-square-deviation |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| Telmi | Telmisartan |
| TIP3P | Transferable intermolecular potential with 3 points |
| Trp | Tryptophan |
| Tyr | Tyrosine |
| UHF | Unrestricted Hartree–Fock |
| Val | Valsartan |
| YAMBER | Yet Another Model Building and Energy Refinement |
| YASARA | Yet Another Scientific Artificial Reality Application |